Zachary Crees

463 total citations
34 papers, 199 citations indexed

About

Zachary Crees is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Zachary Crees has authored 34 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Zachary Crees's work include Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (5 papers) and CAR-T cell therapy research (5 papers). Zachary Crees is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (5 papers) and CAR-T cell therapy research (5 papers). Zachary Crees collaborates with scholars based in United States and Japan. Zachary Crees's co-authors include John F. DiPersio, Keith Stockerl‐Goldstein, Srijayaprakash Uppada, Neelu Puri, Amanda Stone, Armin Ghobadi, Michael P. Rettig, Anna A. Kerege, Vibha Sharma and Joshua Klopper and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zachary Crees

26 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zachary Crees United States	9	98	69	38	31	26	34	199
Simona Barbato Italy	8	190 1.9×	79 1.1×	17 0.4×	71 2.3×	10 0.4×	23	265
Juliana M. Benito United States	5	125 1.3×	50 0.7×	16 0.4×	70 2.3×	24 0.9×	10	230
Karen Cravero United States	10	119 1.2×	94 1.4×	55 1.4×	11 0.4×	19 0.7×	20	281
Andrés López‐Hernandez Spain	4	74 0.8×	61 0.9×	61 1.6×	8 0.3×	28 1.1×	5	224
Pingyong Yi China	9	40 0.4×	75 1.1×	72 1.9×	9 0.3×	35 1.3×	14	149
Ping Qiang China	9	244 2.5×	111 1.6×	13 0.3×	52 1.7×	45 1.7×	30	352
Weijian Zhu China	8	193 2.0×	29 0.4×	11 0.3×	10 0.3×	19 0.7×	23	258
Te-Sheng Chang Taiwan	6	146 1.5×	82 1.2×	23 0.6×	6 0.2×	45 1.7×	7	353

Countries citing papers authored by Zachary Crees

Since Specialization

Citations

This map shows the geographic impact of Zachary Crees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zachary Crees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zachary Crees more than expected).

Fields of papers citing papers by Zachary Crees

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zachary Crees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zachary Crees. The network helps show where Zachary Crees may publish in the future.

Co-authorship network of co-authors of Zachary Crees

This figure shows the co-authorship network connecting the top 25 collaborators of Zachary Crees. A scholar is included among the top collaborators of Zachary Crees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zachary Crees. Zachary Crees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crees, Zachary, Keith Stockerl-Goldstein, Feng Gao, et al.. (2025). A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Transplantation and Cellular Therapy. 32(3). 231.e1–231.e4.

Zhao, Peter Y., Ningying Wu, Feng Gao, et al.. (2024). Waning Long Term Efficacy of COVID-19 Post-Transplant Vaccination for Prevention of COVID-19 Adverse Events in Transplant and Cellular Therapy (TCT) Patients. Blood. 144(Supplement 1). 3532–3532.

Shah, Yash, Mark A. Fiala, Keith Stockerl‐Goldstein, et al.. (2024). Impact of Absolute Lymphocyte Counts (ALC) on Outcomes Following Bispecific Antibody Therapy in Patients with Relapsed/Refractory Multiple Myeloma Patients: A Single Center Real-World Experience. Blood. 144(Supplement 1). 3792.1–3792.1.

Crees, Zachary, Michael P. Rettig, Reyka G. Jayasinghe, et al.. (2024). Motixafortide (CXCR4 Inhibition) Alone and in Combination with Natalizumab (VLA-4 Inhibition) As a Novel Regimen to Mobilize Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease: A First-in-Human, Proof-of-Principle Safety and Feasibility Study. Blood. 144(Supplement 1). 145–145. 2 indexed citations

Goldsmith, Scott, Michael Slade, Mark A. Fiala, et al.. (2024). A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma. Annals of Hematology. 103(11). 4557–4565. 1 indexed citations

Crees, Zachary, et al.. (2024). Prolonged CXCR4 Receptor Occupancy By Motixafortide Following a Single Subcutaneous Injection Is Associated with Extended Mobilization of CD34+ Cells in Peripheral Blood for > 24 Hours. Transplantation and Cellular Therapy. 30(2). S390–S390. 1 indexed citations

Crees, Zachary, Michael Slade, Mark A. Schroeder, et al.. (2023). Patient Recorded Outcomes from a Randomized, Controlled Phase 2 Trial of E-Selectin Inhibition with Uproleselan Vs Placebo to Reduce GI Toxicity during Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Blood. 142(Supplement 1). 2217–2217. 1 indexed citations

Crees, Zachary, Miriam Kim, Michael D. Bern, et al.. (2023). Immune Adjuvant Therapy With Interleukin-7 in a Lymphopenic Patient With Aplastic Anemia and Mucormycosis. Critical Care Explorations. 5(10). e0990–e0990. 1 indexed citations

Crees, Zachary, Keith Stockerl‐Goldstein, Mark A. Schroeder, et al.. (2023). Use of Combination Premedication Prior to Motixafortide Administration Reduced Severity and Frequency of AEs in the Phase 3 Genesis Trial - a Single Center Analysis. Blood. 142(Supplement 1). 3522–3522.

10.

Slade, Michael, Mark A. Fiala, Zachary Crees, et al.. (2023). Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study. Leukemia Research. 127. 107037–107037. 2 indexed citations

11.

Slade, Michael, Mark A. Fiala, Mark A. Zaydman, et al.. (2022). Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma. Blood. 140(Supplement 1). 4376–4377. 4 indexed citations

12.

Crees, Zachary & Armin Ghobadi. (2021). Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T. Cancers. 13(20). 5181–5181. 13 indexed citations

13.

Crees, Zachary, et al.. (2020). EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 12. 3863568771–3863568771. 11 indexed citations

14.

Crees, Zachary, et al.. (2017). Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma. 3(1). 49–52.

15.

Crees, Zachary, et al.. (2017). Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma. SHILAP Revista de lepidopterología. 3(1). 49–52. 2 indexed citations

16.

Crees, Zachary, et al.. (2014). Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy. Current Pharmaceutical Design. 20(41). 6422–6437. 32 indexed citations

17.

Stone, Amanda, et al.. (2014). Targeting c-Met in melanoma. Cancer Biology & Therapy. 15(9). 1129–1141. 35 indexed citations

18.

Li, Mingyu, Lisette A. Maddison, Zachary Crees, & Wenbiao Chen. (2013). Targeted Overexpression of CKI-Insensitive Cyclin-Dependent Kinase 4 Increases Functional β -Cell Number Through Enhanced Self-Replication in Zebrafish. Zebrafish. 10(2). 170–176. 8 indexed citations

19.

Puri, Neelu, et al.. (2013). hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang. OncoTargets and Therapy. 7. 23–23. 11 indexed citations

20.

Sharma, Vibha, et al.. (2010). Thyroid Cancer Resistance to Vitamin D Receptor Activation Is Associated with 24-Hydroxylase Levels But Not the ff FokI Polymorphism. Thyroid. 20(10). 1103–1111. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Barbato Breakdown of academic impact, for papers by Juliana M. Benito Breakdown of academic impact, for papers by Karen Cravero Breakdown of academic impact, for papers by Andrés López‐Hernandez Breakdown of academic impact, for papers by Pingyong Yi Breakdown of academic impact, for papers by Ping Qiang Breakdown of academic impact, for papers by Weijian Zhu Breakdown of academic impact, for papers by Te-Sheng Chang